Yasunaga Y - Search Results

1

A novel human cancer culture model for the study of prostate cancer.

Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim JS. Yasunaga Y, et al. Oncogene. 2001 Nov 29;20(55):8036-41. doi: 10.1038/sj.onc.1205002. Oncogene. 2001. PMID: 11753687

2

Cadmium-induced neoplastic transformation of human prostate epithelial cells.

Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM, Srivastava S, Rhim JS. Nakamura K, et al. Among authors: yasunaga y. Int J Oncol. 2002 Mar;20(3):543-7. Int J Oncol. 2002. PMID: 11836566

3

Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.

Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S, Rhim JS. Nakamura K, et al. Among authors: yasunaga y. Int J Oncol. 2002 Oct;21(4):825-30. Int J Oncol. 2002. PMID: 12239622

4

A novel neoplastic primary tumor-derived human prostate epithelial cell line.

Ko D, Gu Y, Yasunaga Y, Nakamura K, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Arnstein P, Taylor DO, Hukku B, Rhim JS. Ko D, et al. Among authors: yasunaga y. Int J Oncol. 2003 Jun;22(6):1311-7. Int J Oncol. 2003. PMID: 12738999

5

A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.

Gu Y, Kim KH, Ko D, Nakamura K, Yasunaga Y, Moul JW, Srivastava S, Arnstein P, Rhim JS. Gu Y, et al. Among authors: yasunaga y. Int J Oncol. 2004 Oct;25(4):1057-64. Int J Oncol. 2004. PMID: 15375556

6

A novel human cell culture model for the study of familial prostate cancer.

Yasunaga Y, Nakamura K, Ewing CM, Isaacs WB, Hukku B, Rhim JS. Yasunaga Y, et al. Cancer Res. 2001 Aug 15;61(16):5969-73. Cancer Res. 2001. PMID: 11507036

7

Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment.

Nakai Y, Nishimura K, Nakayama M, Uemura M, Takayama H, Nonomura N, Tsujimura A; Osaka CRPC Clinical Study Collaboration. Nakai Y, et al. Int J Clin Oncol. 2014 Feb;19(1):165-72. doi: 10.1007/s10147-013-0536-7. Epub 2013 Mar 1. Int J Clin Oncol. 2014. PMID: 23456140

8

Incidence of prostatic intra-epithelial neoplasia in Osaka, Japan.

Fujita MQ, Shin M, Yasunaga Y, Sekii K, Itatani H, Tsujimura T, Miki T, Okuyama A, Aozasa K. Fujita MQ, et al. Among authors: yasunaga y. Int J Cancer. 1997 Dec 10;73(6):808-11. doi: 10.1002/(sici)1097-0215(19971210)73:6<808::aid-ijc6>3.0.co;2-6. Int J Cancer. 1997. PMID: 9399656 Free article.

9

Low doses of oral dexamethasone for hormone-refractory prostate carcinoma.

Nishimura K, Nonomura N, Yasunaga Y, Takaha N, Inoue H, Sugao H, Yamaguchi S, Ukimura O, Miki T, Okuyama A. Nishimura K, et al. Among authors: yasunaga y. Cancer. 2000 Dec 15;89(12):2570-6. doi: 10.1002/1097-0142(20001215)89:12<2570::aid-cncr9>3.0.co;2-h. Cancer. 2000. PMID: 11135218 Clinical Trial.

10

Characteristics of non-Hodgkin's lymphoma complicated by renal cell malignancies.

Ohsawa M, Hashimoto M, Yasunaga Y, Shingu N, Aozasa K. Ohsawa M, et al. Among authors: yasunaga y. Oncology. 1998 Sep-Oct;55(5):482-6. doi: 10.1159/000011899. Oncology. 1998. PMID: 9732229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page